Success Metrics

Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(67%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(3)

Detailed Status

Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated267%
withdrawn133%

Recent Activity

0 active trials
Showing 3 of 3
terminatednot_applicable

The Leaflex™ Brazilian Standalone Study

NCT05052684
withdrawnnot_applicable

The Leaflex™ Early Feasibility Study

NCT04636073
terminatednot_applicable

The Leaflex™ Standalone Study Protocol

NCT04649099

Clinical Trials (3)

Showing 3 of 3 trials
NCT05052684Not Applicable

The Leaflex™ Brazilian Standalone Study

Terminated
NCT04636073Not Applicable

The Leaflex™ Early Feasibility Study

Withdrawn
NCT04649099Not Applicable

The Leaflex™ Standalone Study Protocol

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3